DFDA

Statins (e.g., Atorvastatin)

Treatment for Non Rheumatic Calcific Aortic Valve Disease

Typical Dosage: 10-80mg daily (Atorvastatin)

Effectiveness
5%
Safety Score
65%
Clinical Trials
150
Participants
60K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
10-80mg daily (Atorvastatin)
Time to Effect
Not applicable (no effect on AS progression)
Treatment Duration
Lifetime (for lipid management)
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$100
Side Effect Mgmt:$50
Total Annual:$200
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0
Statins (e.g., Atorvastatin) Outcomes

for Non Rheumatic Calcific Aortic Valve Disease

Efficacy Outcomes
Overall Effectiveness
+5%
Common Side Effects
Myalgia
+10%
Liver enzyme elevation
+3%
Gastrointestinal upset
+5%

Sources:

nih.gov
ahajournals.org
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov